Beijing Tong Ren Tang Chinese Medicine Company Limited
3613.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.66B
Close$
$11.75
110.2% upside
Current Fair Value
110.2% upsideUndervalued by 110.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.66 Billion |
|---|---|
| Enterprise Value | $2.63 Billion |
| Dividend Yield | $0.40 (7.18%) |
| Earnings per Share | $0.47 |
| Beta | 0.35 |
| Outstanding Shares | 837,100,000 |
Return
| Return on Equity | 11.34% |
|---|---|
| Return on Assets | 10.19% |
| Return on Invested Capital | 12.43% |
Valuation & Multiples
| P/E Ratio | 10.05 |
|---|---|
| PEG | 14.62 |
| Price to Sales | 5.59 |
| Price to Book Ratio | 1.12 |
| Enterprise Value to Revenue | 1.59 |
| Enterprise Value to EBIT | 4.9 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$601.89 M
Average shareholder expectationNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Beijing Tong Ren Tang Chinese Medicine Company Limited
763 employees
CEO: Wang Chi Beijing Tong Ren Tang Chinese Medicine Company Limited, encompassing its various affiliates, specializes in the production, distribution, and direct sale of traditional Chinese medicine and wellness items, catering to both corporate dist...